- Home
- AUPH vs ACDC Comparison
AUPH vs ACDC Comparison
Compare AUPH & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- ACDC
- Stock Information
- Founded
- AUPH 1993
- ACDC 2014
- Country
- AUPH Canada
- ACDC United States
- Employees
- AUPH N/A
- ACDC N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- ACDC Oilfield Services/Equipment
- Sector
- AUPH Health Care
- ACDC Energy
- Exchange
- AUPH Nasdaq
- ACDC Nasdaq
- Market Cap
- AUPH 1.1B
- ACDC 1.1B
- IPO Year
- AUPH 1999
- ACDC 2022
- Fundamental
- Price
- AUPH $8.77
- ACDC $7.99
- Analyst Decision
- AUPH Strong Buy
- ACDC Hold
- Analyst Count
- AUPH 2
- ACDC 5
- Target Price
- AUPH $11.50
- ACDC $7.10
- AVG Volume (30 Days)
- AUPH 1.4M
- ACDC 981.5K
- Earning Date
- AUPH 07-31-2025
- ACDC 08-07-2025
- Dividend Yield
- AUPH N/A
- ACDC N/A
- EPS Growth
- AUPH N/A
- ACDC N/A
- EPS
- AUPH 0.27
- ACDC N/A
- Revenue
- AUPH $247,295,000.00
- ACDC $2,209,700,000.00
- Revenue This Year
- AUPH $12.15
- ACDC N/A
- Revenue Next Year
- AUPH $18.31
- ACDC $0.09
- P/E Ratio
- AUPH $31.76
- ACDC N/A
- Revenue Growth
- AUPH 29.20
- ACDC N/A
- 52 Week Low
- AUPH $5.20
- ACDC $3.83
- 52 Week High
- AUPH $10.67
- ACDC $10.70
- Technical
- Relative Strength Index (RSI)
- AUPH 66.00
- ACDC 48.98
- Support Level
- AUPH $7.71
- ACDC $7.20
- Resistance Level
- AUPH $8.29
- ACDC $8.43
- Average True Range (ATR)
- AUPH 0.25
- ACDC 0.72
- MACD
- AUPH 0.03
- ACDC -0.28
- Stochastic Oscillator
- AUPH 84.40
- ACDC 23.66
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.